Novel Drug Candidate Aims To Tackle Superbug Infections In Cystic Fibrosis Patients

In a world where antibiotics are becoming increasingly unsuccessful at treating infections, those who suffer worst are often the sick and the young. Unfortunately, in the case of Cystic Fibrosis, patients often check off both these boxes. The French bio-pharmaceutical company Antabio is working to develop a way to help these vulnerable patients, and this month they received a $4.4 million dollar grant to help ensure they achieve their goal